Subjective Experience and Dopamine D2 Receptor Occupancy in Patients Treated with Antipsychotics: Clinical Implications
Authors:
Open Access
- 1 May 2004
- journal article
- review article
- Published by SAGE Publications in The Canadian Journal of Psychiatry
- Vol. 49 (5) , 290-296
Abstract
Objectives: This paper gives an overview of studies on the association between dopaminergic neurotransmission and the subjective experience of patients with schizophrenia. Methods: We undertook a review of the literature. Results: Dopaminergic neurotransmission may be relevant for subjective experience. Higher striatal D2 receptor occupancy by typical and atypical antipsychotics is related to worse subjective experience, more severe negative symptoms, and depression. Individuals with lower baseline dopamine function are at an increased risk for dysphoric responses during antipsychotic therapy with dopaminergic-blocking drugs. There is preliminary evidence that a window of striatal D2 receptor occupancy between 60% and 70% is optimal for the subjective experience of patients. These occupancies are often reached even with low dosages of antipsychotic drugs. Conclusions: Reaching an optimal dopamine D2 receptor occupancy is clinically relevant, since subjective experience associated with antipsychotic medication is related to medication compliance. Antipsychotic drug dosages often need to be lower than levels in common use.Keywords
This publication has 49 references indexed in Scilit:
- Atypical Antipsychotics: Mechanism of ActionThe Canadian Journal of Psychiatry, 2002
- What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?Brain Research Reviews, 1998
- Behavioral functions of nucleus accumbens dopamine: Empirical and conceptual problems with the anhedonia hypothesisNeuroscience & Biobehavioral Reviews, 1997
- The involvement of nucleus accumbens dopamine in appetitive and aversive motivationBehavioural Brain Research, 1994
- Drug craving and positive/negative hedonic brain substrates activated by addicting drugsSeminars in Neuroscience, 1993
- Neuronal activity in monkey ventral striatum related to the expectation of rewardJournal of Neuroscience, 1992
- Is neuroleptic dysphoria a healthy response?Comprehensive Psychiatry, 1989
- Neuroleptics and operant behavior: The anhedonia hypothesisBehavioral and Brain Sciences, 1982
- Subjective Response to Antipsychotic DrugsArchives of General Psychiatry, 1981
- Why Do Schizophrenic Patients Refuse to Take Their Drugs?Archives of General Psychiatry, 1974